Ionotropic glutamatergic neurotransmission in the ventral tegmental area modulates ΔFosB expression in the nucleus accumbens and abstinence syndrome in morphine withdrawal rats

European Journal of Pharmacology

Volumn 527, Issue 1-3, 2005, Pages 94-104

  Wang, Hui Ling ^a   Xiang, Xiao Hui ^a   Yuan Guo, ^a   Wu, Wei Ran ^b   Cao, Dong Yuan ^a   Wang, Hui Sheng ^a   Zhao, Yan ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

FosB; DNQX; Glutamate receptor; MK 801; Morphine withdrawal; Nucleus accumbens; Ventral tegmental area

Indexed keywords

6,7 DINITRO 2,3 QUINOXALINEDIONE; DIZOCILPINE; MORPHINE; NALOXONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ACTIVITY; CONTROLLED STUDY; CORRELATION FUNCTION; DRUG DEPENDENCE; GENE EXPRESSION REGULATION; JUMPING; MALE; MICROINJECTION; NERVE CELL; NEUROTRANSMISSION; NONHUMAN; NUCLEUS ACCUMBENS; PRECIPITATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RECEPTOR BLOCKING; TEGMENTUM; WEIGHT REDUCTION; WET DOG SHAKES; WITHDRAWAL SYNDROME;

ANIMALS; DIZOCILPINE MALEATE; EXCITATORY AMINO ACID ANTAGONISTS; IMMUNOHISTOCHEMISTRY; MALE; MICROINJECTIONS; MORPHINE; MORPHINE DEPENDENCE; NALOXONE; NUCLEUS ACCUMBENS; PROTEIN ISOFORMS; PROTO-ONCOGENE PROTEINS C-FOS; QUINOXALINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, N-METHYL-D-ASPARTATE; SUBSTANCE WITHDRAWAL SYNDROME; SYNAPTIC TRANSMISSION; VENTRAL TEGMENTAL AREA;

EID: 28544444149     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2005.10.017     Document Type: Article

References (85)

1. G.K. Aghajanian, J.H. Kogan, and B. Moghaddam Opiate withdrawal increases glutamate and aspartate efflux in the locus coeruleus: an in vivo microdialysis study Brain Res. 636 1994 126 130
2. H. Akaoka, and G. Aston-Jones Opiate withdrawal-induced hyperactivity of locus coeruleus neurons is substantially mediated by augmented excitatory amino acid input J. Neurosci. 11 1991 3830 3839
3. G.F. Alheid, and L. Heimer Theories of basal forebrain organization and the "emotional motor system" Prog. Brain Res. 107 1996 461 484
4. F. Aricioglu-Kartal, H. Kayir, and I. Tayfun Uzbay Effects of harman and harmine on naloxone-precipitated withdrawal syndrome in morphine-dependent rats Life Sci. 73 2003 2363 2371
5. V. Bassareo, and G. Di Chiara Differential influence of associative and nonassociative learning mechanisms on the responsiveness of prefrontal and accumbal dopamine transmission to food stimuli in rats fed ad libitum J. Neurosci. 17 1997 851 861
6. L.J. Bristow, J.E. Hogg, and P.H. Hutson Competitive and glycine/NMDA receptor antagonists attenuate withdrawal-induced behaviours and increased hippocampal acetylcholine efflux in morphine-dependent rats Neuropharmacology 36 1997 241 250
7. S.L. Cappendijk, R. de Vries, and M.R. Dzoljic Excitatory amino acid receptor antagonists and naloxone-precipitated withdrawal syndrome in morphine-dependent mice Eur. Neuropsychopharmacol. 3 1993 111 116
8. W.A. Carlezon, V.A. Boundy, S.B. Lane, R.G. Kalb, R.L. Neve, and E.J. Nestler Sensitization to morphine induced by viralm editated gene transfer Science 277 1997 812 814
9. W.A. Carlezon, C.N. Haile, R. Coopersmith, Y. Hayashi, R. Malinow, R.L. Neve, and E.J. Nestler Distinct sites of opiate reward and aversion within the midbrain identified using a herpes simplex virus vector expressing GluR1 J. Neurosci. 220 2000 1 5
10. L. Carrie, M.S. Walters, G. Aston-Jones, and J.P. Druhan Expression of Fos-related antigens in the nucleus accumbens during opiate withdrawal and their attenuation by a D2 dopamine receptor agonist Neuropsychopharmacology 23 2000 307 315
11. M.A. Casu, D. Dinucci, G. Colombo, G.L. Gessa, and L. Pani Reduced DAT- and DBH-immunostaining in the limbic system of sardinian alcohol-preferring rats Brain Res. 948 2002 192 202
12. J.S. Chen, M.B. Kelz, B.T. Hope, Y. Nakabeppu, and E.J. Neslter Chronic Fos-related antigens: stable variants of ΔFosB induced in brain by chronic treatments J. Neurosci. 17 1997 4933 4941
13. J.S. Chen, M.B. Kelz, G.Q Zeng, N. Sakai, C. Steffen, P.E. Shockeet, M. Picciotto, R.S. Duman, and E.J. Nestler Transgenic animals with inducible, targeted gene expression in brain Mol. Pharmacol. 54 1998 495 503
14. W.B. Chou, Y.M. Zeng, S.H.M. Duan, W.H. Zhou, J. Gu, and G.D. Yang M2 muscarinic receptor of spinal cord mediated increase of nNOS expression in locus coeruleus during morphine withdrawal Acta Pharmacol. Sin. 23 2002 691 697
15. G. Di Chiara, and A. Imperato Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats Proc. Natl. Acad. Sci. U. S. A. 85 1988 5274 5278
16. E. Fernandez-Espejo, M. Cador, and L. Stinus Ethopharmacological analysis of naloxone-precipitated morphine withdrawal syndrome in rats: a newly-developed "etho-score" Psychopharmacology 122 1995 122 130
17. L.W. Fitzgerald, J. Ortiz, A.G. Hamedani, and E.J. Nestler Drugs of abuse and stress increase the expression of GluR1 and NMDAR1 glutamate receptor subunits in the rat ventral tegmental area: common adaptations among cross-sensitizing agents J. Neurosci. 16 1996 274 282
18. M.E. Fundytus, and T.J. Coderre Effect of activity at metabotropic, as well as ionotropic (NMDA), glutamate receptors on morphine dependence Br. J. Pharmacol. 113 1994 1215 1220
19. V.F. Gellert, and S.G. Holtzman Development and maintenance of morphine tolerance and dependence in the rat by scheduled access to morphine drinking solutions J. Pharmacol. Exp. Ther. 205 1978 536 546
20. C.R. Genfen, T.M. Engber, L.C. Mahan, Z. Susel, T.N. Chase, F.J. Monsma Jr., and D.R. Sibley D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons Science 250 1990 1429 1432
21. F. Georges, L. Stinus, and C. Le Moine Mapping of c-fos gene expression in the brain during morphine dependence and precipitated withdrawal, and phenotypic identification of the striatal neurons Eur. J. Neurosci. 12 2000 4475 4486
22. C. Grande, H.W. Zhu, A.B. Martin, M. Lee, O. Ortiz, N. Hiroi, and R. Moratalla Chronic Treatment with atypical neuroleptics induces striosomal FosB/ΔFosB expression in rats Biol. Psychiatry 55 2004 457 463
23. G.C. Harris, and G. Aston-Jones Involvement of D2 dopamine receptors in the nucleus accumbens in the opiate withdrawal syndrome Nature 371 1994 155 157
24. M.D. Hayward, R.S. Duman, and E.J. Nestler Induction of the c-fos proto-oncogene opiate withdrawal in the locus coeruleus and other regions of rat brain Brain Res. 525 1990 256 266
25. L. Heimer, D.S. Zahm, and G.F. Alheid G. Paxinons Base Ganglia, in the Rat Nervous System 2nd ed. 1995 579 628
26. S.E. Hemby Morphine-induced alterations in gene expression of calbindin immunopositive neurons in nucleus accumbens shell and core Neuroscience 126 2004 689 703
27. N. Hiroi, and A.M. Graybiel Atypical and typical neuroleptic treatments induce distinct programs of transcription factor expression in the striatum J. Comp. Neurol. 374 1996 70 83
28. N. Hiroi, J.R. Brown, C.N. Haile, H. Ye, M.E. Greemberg, and E.J. Nestler FosB mutant mice: loss of chronic cocaine induction of Fos-related proteins and heightened sensitivity to cocaine's psychomotor and rewarding effects Proc. Natl. Acad. Sci. U. S. A. 16 1997 10397 10402
29. N. Hiroi, A.M. Martin, C. Grande, L. Alberti, A. Rivera, and R. Moratalla Molecular dissection of dopamine receptor signaling J. Chem. Neuroanat. 23 2002 237 242
30. K.M. Hollen, Y. Nakabeppu, and S.W. Davies Changes in expression of ΔFosB and Fos family proteins following NMDA receptor activation in the rat striatum Mol. Brain Res. 47 1997 31 43
31. M. Hong, B. Milne, and K. Jhamandas Evidence for the involvement of excitatory amino acid pathways in the development of precipitated withdrawal from acute and chronic morphine: an in vivo voltammetric study in the rat locus coeruleus Brain Res. 623 1993 131 141
32. B.T. Hope, M.B. Kelz, R.S. Duman, and E.J. Nestler Chronic electroconvulsive seizure (ECS) treatment results in expression and AP-1 complex in brain with altered composition and characteristics J. Neurosci. 14 1994 4318 4328
33. B.T. Hope, H.E. Nye, M.B. Kelz, D.W. Self, M. Iadarola, Y. Nakabeppu, R.S. Duman, and E.J. Nestler Induction of a long-lasting AP-1 complex composed of altered Fos-like proteins in brain by chronic cocaine and other chronic treatments Neuron 13 1994 1235 1244
34. N. Hussain, B.A. Flumerfelt, and N. Rajakumar Muscarinic, adenosine A2 and histamine H3 receptor modulation of haloperidol-induced c-Fos expression in the striatum and nucleus accumbens Neuroscience 112 2002 427 438
35. M. Inoue, M. Mishina, and H. Ueda Locus-specific rescue of Glu Repsilon I NMDA receptors in mutant mice identifies the brain regions important for morphine tolerance and dependence J. Neurosci. 23 2003 6529 6530
36. J.H. Jhamandas, K.H. Harris, T. Petron, and K.H. Jhamandas Activation of nitric oxide-synthesizing neurons during precipitated morphine withdrawal NeuroReport. 7 1996 2843 2846
37. P.W. Kalivas Neurotransmitter regulation of dopamine neurons in the ventral tegmental area Brain Res. Rev. 18 1993 75 113
38. P.W. Kalivas, and P. Duffy Repeated cocaine administration alters extracellular glutamate in the ventral tegmental area J. Neurochem. 70 1998 1497 1502
39. M.B. Kelz, J. Chen, W.A. Carlezon Jr., K. Whisler, L. Gilden, A.M. Beckman, C. Steffen, Y.J. Zhang, L. Marotti, D.W. Self, T. Tkatch, G. Baranauskas, D.J. Surmeier, R.L. Neve, R.S. Duman, M.R. Picciotto, and E.J. Nestler Expression of the transcription factor deltaFosB in the brain controls sensitivity to cocaine Nature 401 1999 272 276
40. G.F. Koob, and F.E. Bloom Cellular and molecular mechanisms of drug dependence Science 242 1988 715 723
41. L.B. Kozell, and C.K. Meshul Nerve terminal glutamate immunoreactivity in the rat nucleus accumbens and ventral tegmental area after a short withdrawal from cocaine Synapse 51 2004 224 232
42. M.B. Leal, K. Michelin, D.O. Souza, and E. Elisabetsky Ibogaine attenuation of morphine withdrawal in mice: role of glutamate N-methyl-d-aspartate receptors Prog. Neuro-Psychopharmacol. Biol. Psychiatry 27 2003 781 785
43. C. Le Moine, E. Normand, A.F. Guitteny, B. Fouque, R. Teoule, and B. Bloch Dopamine receptor gene expression by enkephalin neurons in rat forebrain Proc. Natl. Acad. Sci. U. S. A. 87 1990 230 234
44. J.L. Liu, J. Nickolenko, and F.R. Sharp Morphine induces c-fos and junB in striatum and nucleus accumbens via D1 and N-methyl-d-aspartate receptors Proc. Natl. Acad. Sci. U. S. A. 91 1994 8538 8541
45. T. Maeda, S. Kishioka, N. Inoue, N. Shimizu, Y. Fukazawa, and H. Ozaki Yamamoto Naloxone precipitated morphine withdrawal elicits increases in c-fos mRNA expression in restricted region of the infant rat brain Jpn. J. Pharmacol. 90 2002 270 275
46. B.H. Manning, J. Mao, H. Frenk, D.D. Price, and D.J. Mayer Continuous co-administration of dextromethorphan or MK-801 with morphine: attenuation of morphine dependence and naloxone-reversible attenuation of morphine tolerance Pain 67 1996 79 88
47. G.L. Mclemore, B. Kest, and C.E. Inturrisi The effects of LY293558, an AMPA receptor antagonist, on acute and chronic morphine dependence Brain Res. 778 1997 120 126
48. R. Moratalla, M. Xu, S. Tonegawa, and A.M. Graybiel Cellular responses to psychomotor stimulant and neuroleptic drugs are abnormal in mice lacking the D1 dopamine receptor Proc. Natl. Acad. Sci. U. S. A. 93 1996 14928 14933
49. R. Moratalla, B. Elibol, M. Vallejo, and A.M. Graybiel Network-level changes in expression of inducible Fos-Jun proteins in the striatum during chronic cocaine treatment and withdrawal Neuron 17 1996 147 156
50. T.A. Morris, N. Jafari, and R.J. Delornzo Chronic ΔFosB expression and increased AP-1 transcription factor binding are associated with the long term plasticity changes in epilepsy Mol. Brain Res. 79 2000 138 149
51. D.L. Muller, and E.M. Uniterwald D1 dopamine receptors modulate {Delta} FosB induction in rats striatum after intermittent morphine administration J. Pharmacol. Exp. Ther. 314 1 2005 148 154
52. C.A. Murphy, H. Russig, M.A. Pezze, B. Ferger, and J. Feldon Amphetamine withdrawal modulates FosB expression in mesolimbic dopaminergic target nuclei: effects of different schedules of administration Neuropharmacology 44 2003 926 939
53. E.J. Nestler, M. Barrot, and D.W. Self ΔFosB: a sustained molecular switch for addiction Proc. Natl. Acad. Sci. U. S. A. 98 2001 11042 11046
54. H.E. Nye, and E.J. Nestler Induction of chronic Fras (Fos-related antigens) in rat brain by chronic morphine administration Mol. Pharmacol. 49 1996 636 645
55. H.E. Nye, B.T. Hope, M.B. Kelz, M.J. Iadarola, and E.J. Nestler Pharmacological studies of the regulation of chronic Fos-related antigen induction by cocaine in striatum and nucleus accumbens J. Pharmacol. Exp. Ther. 275 1995 1671 1680
56. J. Ortiz, L.W. Fitzgerald, M. Chailton, S. Lane, L. Trevisan, X. Guitar, W. Shoemaker, R.S. Duman, and E.J. Nestler Biochemical actions of chronic ethanol exposure in the mesolimbic dopamine system Synapse 21 1995 289 298
57. Paxinos, and Watson atlas The Rat Brain in Stereotaxic Coordinates third ed. 1998 Academic Press Sydney
58. H.O. Pettit, and J.B. Justice Dopamine in the nucleus accumbens during cocaine self-administration as studied by in vivo microdialysis Pharmacol. Biochem. Behav. 34 1989 899 904
59. E.M. Pich, S.R. Pagliuusi, M. Tessari, D. Talabot-Ayer, R. Hooft van Huijsduijnen, and C. Chiamulera Common neural substrates for the addictive properties of nicotine and cocaine Science 275 1997 83 86
60. P. Popik, and W. Kolasiewicz Mesolimbic NMDA receptors are implicated in the expression of conditioned morphine reward Naunyn-Schmiedeberg's Arch. Pharmacol. 359 1999 288 294
61. P. Popik, and P. Skolnick The NMDA antagonist memantine blocks the expression and maintenance of morphine dependence Pharmacol. Biochem. Behav. 53 1996 791 798
62. P. Popik, J. Mamczarz, M. Fraczek, G. Widla, M. Hesselink, and W. Danysz Inhibition of reinforcing effects of morphine and naloxone-precipitated opioid withdrawal by novel glycine site and uncompetitive NMDA receptor antagonists Neuropharmacology 37 1998 1033 1042
63. K. Rasmussen The role of the locus coeruleus and N-methyl-d-aspartic acid (NMDA) and AMPA receptors in opiate withdrawal Neuropsychopharmacology 13 1995 295 300
64. K. Rasmussen, and J. Vandergiff The selective iGlurl1-4 (AMPA) antagonist LY300168 attenuates morphine-withdrawal-induced activation of locus coeruleus neurons and behavioural signs of morphine withdrawal Neuropharmacology 44 2003 88 92
65. M. Rasmussen, M. Brodsky, and C.E. Inturrisi NMDA antagonists and clonidine block c-fos expression during morphine withdrawal Synapse 20 1995 68 74
66. K. Rasmussen, W.T. Kendrick, J.H. Kogan, and G.K. Aghajanian A selective AMPA antagonist, LY293558, suppresses morphine withdrawal-induced activation of locus coeruleus neurons and behavioral signs of morphine withdrawal Neuropsychopharmacology 15 1996 497 505
67. M.J. Sepulveda, L. Hernandez, P. Rada, S. Tucci, and E. Contreras Effect of precipitated withdrawal on extracellular glutamate and aspartate in the nucleus accumbens of chronically morphine-treated rats: an in vivo microdialysis study Pharmacol. Biochem. Behav. 60 1998 255 262
68. S. Spiga, G.P. Serra, M.C. Puddu, M. Foddai, and M. Diana Morphine withdrawal-induced abnormalities in the VTA: confocal laser scanning microscopy Eur. J. Neurosci. 17 2003 605 612
69. R.L. Stornetta, F.E. Norton, and P.G. Guyenet Autonomic areas of rat brain exhibit increased Fos-like immunoreactivity during opiate withdrawal in rats Brain Res. 624 1993 19 28
70. M.F. Suaud-Chagny, K. Chergui, G. Chouvet, and F. Gonon Relationship between dopamine release in the rat nucleus accumbens and the discharge activity of dopaminergic neurons during local in vivo application of amino acids in the ventral tegmental area Neuroscience 49 1992 63 72
71. M.A. Sutton, E.F. Schmidt, K.-H. Chol, C.A. Schad, K. Whisler, D. Simmons, D.A. Karanian, L.M. Monteggia, R.L. Neve, and D.W. Self Extinction-induced upregulation in AMPA receptors reduces cocaine-seeking behaviour Nature 421 2003 70 75
72. L.W. Swanson The projections of the ventral tegmental area and adjacent regions: a combined fluorescent retrograde tracer and immunofluorescence study in the rat Brain Res. Bull. 9 1982 321 353
73. C.J. Swanson, and P.W. Kalivas Regulation of locomotor activity by metabotropic glutamate receptors in the nucleus accumbens and ventral tegmental area J. Pharmacol. Exp. Ther. 292 2000 406 414
74. W. Tang, M. Wesley, W.M. Freeman, B. Liang, and S.E. Hemby Alterations in ionotropic glutamate receptor subunits during binge cocaine self-administration and withdrawal in rats J. Neurochem 89 2004 1021 1033
75. S.N. Thorat, M.J. Barjavel, G.A. Matwyshyn, and H.N. Barghava Comparative effects of NG-monomethyl-l-Arginine and MK-801 on the abstinence syndrome in morphine-dependent mice Brain Res. 642 1994 153 159
76. 2+ channel blocker, on naloxone-induced glutamate levels in the locus coeruleus of opioid-dependent rats Brain Res. 722 1996 212 216
77. K.A. Trujillo, and H. Akil Inhibition of morphine tolerance and dependence by the NMDA receptor antagonist MK-801 Science 251 1991 85 87
78. O. Valverde, and B.P. Roques Cholecystokinin modulates the aversive component of morphine withdrawal syndrome in rats Neurosci. Lett. 244 1998 37 40
79. F. Weiss, Y.L. Hued, U. Ungerstedt, A. Markou, P.M. Plotsky, and G.F. Koob Neurochemical correlates of cocaine and ethanol self-administration Ann. N.Y. Acad. Sci. U.S.A. 654 1992 220 241
80. F.J. White Synaptic regulation of mesocorticolimbic dopamine neurons Annu. Rev. Neurosci. 19 1996 405 436
81. F.J. White, X.-T. Hu, X.-F. Zhang, and M.E. Wolf Repeated administration of cocoine or amphetamine alters neuronal responses to glutamate in the mesoaccumbens dopamine system J. Pharmacol. Exp. Ther. 273 1995 445 454
82. 2a-adrenoreceptor mRNA in brain Mol. Brain Res. 45 1997 154 158
83. Z.X. Xi, and E.A. Stein Blockade of ionotropic glutamatergic transmission in the ventral tegmental area reduces heroin reinforcement in rat Psychopharmacology 164 2002 144 150
84. D.S. Zahm, and J.S. Brog On the significance of subterritories in the "accumbens" part of the rat ventral striatum Neurosciences 50 1992 751 767
85. Q. Zhou, P.L. Greves, F. Ragnar, and F. Nyberg Intracerebroventricular injection of the N-terminal substance P fragment SP1-7 regulates the expression of the N-methyl-d-aspartate receptor NR1, NR2A and NR2B subunit mRNAs in the rat brain Neurosci. Lett. 291 2000 109 112